Immune biomarkers for diagnosis of Axial Spondyloarthriti
Collaboration offers
Information
LICENSING OPPORTUNITY
contact: Sofie Ignoul, PhD
UHasselt - Biomedical Research Institute
T +32 (0) 497 78 01 76 - E: sofie.Ignoul@uhasselt.be
KEY FEATURES AND ADVANTAGES
Diagnostic value of 3 biomarkers, validated in 2 independent cohorts (n=260).
Research ELISA assays translated to high throughput peptide ELISA assays.
Possibility to better diagnose axSpA patients and start correct treatment earlier.
Hasselt University and KU Leuven have a strong IP protection for the biomarkers.
OUTSTANDING OPPORTUNITY
Patent application is available for licensing.
Both universities are searching for interested parties to complete development and commercialization.